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Abstract  
This study evaluated the effects of high-dose of short-term 
creatine supplementation (5g.kg-1.day-1 to 1 week) and long-term 
creatine supplementation (1g.kg-1.day-1 to 4-8 weeks) on kidney 
and liver structure and function of sedentary and exercised 
Wistar rats (Exercise sessions consisted of swimming at 80% of 
maximal work load supported during 5 days per week with daily 
sessions of 60 minutes throughout the duration of the supple-
mentation). Seventy-two animals (245 ± 5g) were divided into 
four groups (n = 18): control diet Sedentary (SED), Creatine diet 
Sedentary (CRE), control diet Exercised (EXE), and Creatine 
diet Exercised (EXECRE). Histological and blood biochemical 
studies were performed after one, four, and eight weeks of 
creatine supplementation and exercise (n = 6). No differences 
were found when comparing SED, EXE and EXECRE groups 
for kidney and liver structure and function at one, four and eight 
weeks. However, the CRE group showed higher levels of 
creatinine (1.1 ± 0.2 vs. 0.4 ± 0.1 mg.dl-1; p < 0.05), and urea (37 
± 3 vs. 19 ± 1 mg.dl-1; p < 0.05) when compared with all others 
groups at four and eight weeks. At eight weeks, the CRE group 
presented increased levels of ALT (41 ± 7 vs. 23 ± 7 U.L-1; p < 
0.05), AST (89 ± 6 vs. 62 ± 5 U.L-1; p < 0.05), GGT (8.0 ± 0.9 
vs. 3.9 ± 1.0 U.L-1; p < 0.05), and AP (125 ± 10 vs. 69 ± 9 U.L-1; 
p < 0.05) also when compared with all others groups. Moreover, 
the CRE group demonstrated some structural alterations indicat-
ing renal and hepatic damage at four and eight weeks, respec-
tively. These results suggest that long-term creatine supplemen-
tation (up to 4-8 weeks) may adversely affect kidney and liver 
structure and function of sedentary but not of exercised rats. 
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Introduction 
 
Creatine (Cr) is an organic compound synthesized mainly 
in the liver and kidneys from the amino acids glycine, 
arginine and methionine (Walker, 1979). Cr plays an 
important role in rapid energy provision during muscle 
contraction involving the transfer of N-phosphoryl group 
from phosphorylcreatine (PCr) to ADP to regenerate ATP 
through a reversible reaction catalyzed by phosphoryl-
creatine kinase (PCK) (Walker, 1979). Its biochemical 
(Greenhaff, 1997), physiological (Greenhaff, 1997), 
ergogenic (Bemben and Lamont, 2005) and therapeutic 
(Gualano et al., 2009; Vieira et al., 2007) roles have been 
extensively investigated. In the last 20 years, Cr has 
become a very popular dietary supplement (Bird, 2003; 
Maughan et al., 2004) but despite its widespread use, 
there is little evidence concerning possible side effects 
(Bizzarini and De Angelis, 2004; Poortmans et al., 2005). 
Studies have found that Cr supplementation can in-
crease skeletal muscle and brain total Cr and PCr concen-
trations, with an even greater degree of increase seen in 
organs with low baseline creatine content such as kidney 
and liver (Ipsiroglu et al., 2001) but the possible side 
effects of Cr supplementation, such as renal dysfunction, 
and hepatotoxicity are still inconclusive (Bizzarini and De 
Angelis, 2004). Because urea, which is one of the 
metabolic products of creatine metabolism, is involved in 
the conversion of toxic compounds such as methylamina 
and formaldehyde, Cr supplementation can also be 
expected to influence this conversion (Poortmans et al., 
2005). There has been some concern regarding the poten-
tial for Cr supplementation toxicity based on two anecdo-
tal human case reports (Pritchard and Kalra, 1998; Thor-
steinsdottir, et al. 2006). However, in humans, most of the 
studies that have examined the potential for toxicity of Cr 
supplementation have not found evidence of side effects 
when consumed at “recommended” doses (Kreider et al., 
2003; Mayhew et al., 2002; Mihic et al., 2000; Poortmans 
and Francaux, 1999; Poortmans et al., 1997; Robinson et 
al., 2000; Terjung et al., 2000; Waldron et al., 2002). In 
animals, the effects of Cr supplementation on renal and 
hepatic structure and function have not been well estab-
lished. Whereas some studies did not report any alteration 
in renal and hepatic function after Cr supplementation 
(Taes et al., 2003; Tarnopolsky et al., 2003), others have 
observed that it can speed up renal and hepatic disease 
progression (Edmunds et al., 2001; Ferreira et al., 2005; 
Tarnopolsky et al., 2003). 
Vieira et al. (2007) demonstrated that Cr supple-
mentation exacerbates all cardinal features of asthma in 
mice with chronic allergic airway inflammation, which 
suggests potential side effects for asthmatic individuals. 
However, the same authors recently demonstrated that 
these pulmonary side effects are completely abolished 
when Cr supplementation in animals with chronic allergic 
airway inflammation is followed by aerobic exercise, 
suggesting that the exercise could to block the possible 
side effects of Cr supplementation (Vieira et al., 2008b). 
Since supraphysiological doses of Cr supplementa-
tion could facilitate the demonstration its potential for 
side effects at the tissue level, in this study we have used 
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histopathological and enzymatic analyses to clarify the 
possible protector effect of exercise during high-dose Cr 
supplementation. In general, renal diseases are 
characterized by the occurrence of morphological lesions 
at any degree of magnification and also by any 
biochemical abnormality (Gregory, 2003), although a 
severe renal disease can be present without clinical signs 
or laboratorial alterations that indicate renal insuficiency 
(Gregory, 2003). Therefore, plasma levels of urea and 
creatinine are classical markers of renal function because 
they represent a simple marker of glomerular filtration 
(Ghosh and Sil, 2007). Liver diseases have presented a 
broad variability in several human and animal studies, as 
well as in the criteria used to categorize the severity of 
hepatotoxicity (Nunez, 2006). Plasma levels of hepatic 
enzymes, such as aspartate aminotranferase (AST), 
alanine aminotransferase (ALT), and alkaline phosphatase 
(AP) are considered valuable for detecting toxic effects on 
the liver (Boada et al., 1999). 
Therefore, the aim of this study was to evaluate the 
effects of supraphysiological doses of loading and 
maintenance phase protocol of Cr supplementation on the 
renal and hepatic structure and function in sedentary and 
exercised Wistar rats. 
 
Methods 
 
All animal care was in accordance with the guidelines of 
the Brazilian College for Animal Experimentation 
(COBEA) and was approved by Animal Research Ethics 
Committee of the University of Vale do Paraíba (L022-
2005-CEP). 
 
Experimental design 
Seventy-two male Wistar rats (245±5g) were housed 
individually (22 ± 3 ºC, relative humidity 60 ± 10%, 
12h/12h light/darkness); food and water was available ad 
libitum. The study was performed for 8 weeks and the 
animals were divided into four groups (n = 18): control 
diet Sedentary (SED), Creatine diet Sedentary (CRE), 
control diet Exercised (EXE), and Creatine diet Exercised 
(EXECRE). To verify the effects of supraphysiological 
doses of Cr loading and maintenance supplementation 
periods, six animals in each group were euthanized by an 
intracardial injection of pentobarbital sodium at the end of 
1, 4, and 8 weeks. 
 
Swimming training  
All the animals were submitted to a swimming adaptation 
period (30 daily minutes without load, during five con-
secutive days) in order to decrease factors related to the 
stress promoted by the swimming activity (Osorio et al., 
2003a; 2003b). During this period, the Cr was not admin-
istered. After adaptation, the animals were individually 
submitted to the maximum load test (MLT) (Guerrero-
Ontiveros and Wallimann, 1998; Ipsiroglu et al., 2001). 
Load cells (lead fish sinkers) were increased at 3 min 
intervals by weights corresponding to 1, 2, 3%, etc. of the 
rat's mass. The load cells were attached to the tail of the 
animal until the maximal work load was reached, which 
was determined at the moment when the animal became 
exhausted (unable to surface after approximately 8-10s). 
This test allowed the working load adjustment for the 
physical training at 80% of the maximal load. The physi-
cal training at 80% of the maximal load was performed in 
groups of six animals due to the more vigorous exercise 
promotion when compared to the individual swimming 
(Osorio et al., 2003a; 2003b). Such training occurred five 
times a week with training daily sessions of 60 minutes 
throughout the duration of the supplementation and only 
in the EXE and EXECRE experimental groups. The 
swimming protocol was performed in an asbestos tank 
with 250 liters of water kept at 31 ± 1 ºC temperature. 
 
Creatine supplementation 
Cr supplementation began one day after the swimming 
adaptation. The animals received the Cr supplementation 
by gavage (Micronized Creatine, Integral Médica®, 
Embu-Guaçu, SP, Brazil). at a dose of 5g.kg -1.day-1 to 1 
week (loading phase) and 1g.kg-1.day-1 to 4-8 weeks after 
loading phase (maintenance phase). Doses were given in 
the afternoon and corresponded 30 min prior to exercise. 
In addition, considering that a dose daily of 300mg 
of creatine per kilogram of body weight is routinely used 
in other animal studies (Brannon et al., 1997; Gagnon et 
al., 2002; McGuire et al., 2002; Young and Young, 2007) 
and is equivalent to the customary loading dose of 
20g.day-1 in a 70 kg person which produces maximal 
effects in 5 days, the Cr supplementation regimen adopted 
in the present study must be considered 
supraphysiological. 
 
Enzymatic measurements 
Forty-eight hours after the last training session and 
creatine administration, animals were anesthetized with 
ketamine (70 mg·kg-1) and xylazine (1 mg·kg-1). The 
abdominal cavity was opened and blood samples (5ml) 
were collected from the inferior cava vein into plastic 
syringes carefully avoiding the formation of bubbles. 
After centrifugation at 1000 rpm for 10 minutes, the 
plasma was collected and biochemical analysis for renal 
function (Urea and Creatinine), and hepatic function 
(Alanine Aminotransferase (ALT), Aspartate 
Aminotransferase (AST), Gamma Glutamyltransferase 
(GGT), Alkaline Phosphatase (AP), Albumin and Total 
Bilirubin, were measured spectrophotometrically 
following the manufacturer’s manual (Hitachi®, Model U-
2001) using commercial kits (Laborlab, Guarulhos, SP, 
Brazil) (Gregory, 2003, Vieira et al, 2008a). 
 
Histological procedures 
After blood collection, the right kidney and right hepatic 
lobe were rapidly removed and fixed in formalin solution 
(10%) for 24 hours and submitted to histological routine. 
The 5µm slides were stained with Hematoxiline/Eosine 
and photographed at 400x magnification, with a digital 
camera (Nikon, CoolPix) attached to an optical micro-
scope (Nikon, Eclipse E200). For kidneys we analysed the 
structure of Bowman capsules, glomerular capillaries, 
intra-capsular spaces, renal tubules, as well as the pres-
ence of leukocytes, red cells and edema formation. For 
liver, we analysed the centrality of nucleus, number of 
hepatocytes with binucleation, congestion of central vein, 
leukocytes infiltration, number of kupffer cells and swell-
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ing lumen by the blood cells and congestion of sinusoids 
(Vieira et al., 2008a). 
 
Statistical analysis 
The results were expressed as mean ± SEM. Two way 
variance analysis (ANOVA) 4 x 3 (group x time) was 
used for repeated measurements among the experimental 
groups in the different experimental periods. The Tukey 
post hoc test was applied for the identification of the 
specific differences in the variables. The level of signifi-
cance was set at p < 0.05. The statistical analysis was 
conducted using the software SPSS 17.0 for Windows 
(SPSS Inc., Chicago, IL). 
 
Results 
 
Effects of creatine supplementation during loading 
phase 
Figure 1 shows the plasma levels of renal (creatinine, 
urea) and hepatic function (ALT, AST, GGT, AP, Albu-
min and Total Bilirubin) markers after 1 week of Cr sup-
plementation. No harmful effects of Cr loading supple-
mentation (5g.kg-1.day-1 for 1 week) on renal and hepatic 
function markers were observed during this phase. Only 
AST presented higher values in the exercised groups 
(EXE and EXECRE) when compared with the sedentary 
groups (SED and CRE) (Figure 1D; p < 0.05). Addition-
ally, renal and hepatic histological evaluation did not 
show any alterations for all groups. 
 
Effects of creatine supplementation during mainte-
nance phase 
Cr supplementation during maintenance phase (1g .kg -
1.day-1 for 4 and 8 weeks after loading phase) led to in-
creased levels of renal function markers (creatinine and 
urea) (Figures 2A and B and 3A and B, respectively). 
However, these results were evident only in CRE group 
when compared with all others groups (p < 0.05).  
After the fourth week of supplementation, the ani-
mals of CRE group had renal corpuscles with outlines of
 
 
 
 
 
Figure 1. Plasma levels of renal and hepatic markers after 1 week creatine supplementation. Experimental Groups: 
Normal diet Sedentary (SED), Creatine diet Sedentary (CRESED), Normal diet Exercised (EXE), Creatine diet 
Exercised (CREEXE). Panels A and B (renal markers): creatinine and urea, respectively; panels C,D,E,F,G and H 
(hepatic markers): alanine aminetransferase (ALT), aspartate aminetransferase (AST), gamma glutamyltransferase 
(GGT), alkaline phosphatase (AP), albumin and total bilirrubin, respectively. * p < 0.05 when compared with all groups. 
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Figure 2. Plasma levels of renal and hepatic markers after 4 weeks creatine supplementation.  Experimental Groups: 
Normal diet Sedentary (SED), Creatine diet Sedentary (CreSED), Normal diet Exercised (EXE), Creatine diet Exer-
cised (CreEXE). Panels A and B (renal markers): creatinine and urea, respectively; panels C,D,E,F,G and H (hepatic 
markers): alanine aminetransferase (ALT), aspartate aminetransferase (AST), gamma glutamyltransferase (GGT), al-
kaline phosphatase (AP), albumin and total bilirrubin, respectively. * p < 0.05 when compared with all groups. 
 
difficult delimitation and irregular Bowman´s capsules, 
glomeruli dilations, and no preserved intra-capsular 
spaces. Renal tubules exhibited cellular morphologic 
regularity (cuboid epithelium), but indefinite tubular 
space (Figure 4). 
Four weeks of creatine supplementation resulted in 
no changes of hepatic markers (ALT, AST, GGT, and 
AP) when compared with all other groups (Figure 2C, D, 
E and F, respectively; p > 0.05), also no changes were 
observed in liver morphology. However, after 8 weeks of 
creatine supplementation, the values of ALT, AST, GGT, 
and AP were significantly higher in the CRE group when 
compared with the values of all others experimental 
groups (p < 0.05) (Figure 3C, D, E and F, respectively). 
These functional alterations were accompanied by some 
histological alterations, like congestion of the central 
vein, some polymorphonuclear inflammatory cells infil-
trate, sinusoids walls showing numerous Kupffer cells 
with swelling lumen by the blood cells (Figure 5). In 
contrast, albumin and total bilirubin levels did not present 
significant alterations during the entire experiment (p > 
0.05). 
 
Discussion 
 
The   key   findings   from   the   present   study   was   the 
demonstration, for the first time, that (a) four weeks of 
supraphysiological doses of Cr supplementation resulted 
in increased creatinine and urea levels and renal tissue 
damage in non trained rats and (b) eight weeks of 
supraphysiological doses of Cr supplementation produced 
increased levels of AST, ALT, GGT and AP and hepatic 
tissue damage in non trained rats. These results suggest 
that side effects of supraphysiological doses of Cr 
supplementation on the kidney and liver are time 
dependent. This study also demonstrated that these 
possible renal and hepatic side effects are not present in 
Cr supplemented groups submitted to swimming training 
(EXECRE), suggesting that the exercise could to block 
the side effects of high-dose Cr supplementation. 
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Figure 3. Plasma levels of renal and hepatic markers after 8 weeks creatine supplementation. Experimental Groups: 
Normal diet Sedentary (SED), Creatine diet Sedentary (CRESED), Normal diet Exercised (EXE), Creatine diet Exer-
cised (CREEXE). Panels A and B (renal markers): creatinine and urea, respectively; panels C,D,E,F,G and H (hepatic 
markers): alanine aminetransferase (ALT), aspartate aminetransferase (AST), gamma glutamyltransferase (GGT), al-
kaline phosphatase (AP), albumin and total bilirrubin, respectively. * p < 0.05 when compared with all groups. 
 
Oral Cr supplementation in humans and rats has 
been proven to increase physical performance (Bemben 
and Lamont, 2005; Kreider, 2003) and some studies have 
demonstrated benefits in certain pathological conditions 
(Bender et al., 2005; Jeong et al., 2000). So, the Cr sup-
plementation has become popular among athletes due to a 
performance-enhancing potential. However, as an avail-
able and legal product, it can be easily purchased in nutri-
tion stores or supermarkets, and the potential effect on 
muscle mass enhancement among untrained and/or among 
non-healthy people may represent a major concern, be-
cause its side effects have not been well established. 
The clinical trials studies conducted with Cr using 
healthy adults are usually divided in two phases: (a) initial 
phase with supplementation of high Cr doses (20 to 30 g 
daily) during 5 to 7 days (Loading Phase), immediately 
followed by (b) a maintenance phase, with small Cr 
doses, 1/5 of the initial dose (4 to 6 g daily), for several 
weeks (Bemben and Lamont, 2005; Bird, 2003; Shao and 
Hathcock, 2006). Using this Cr supplementation protocol, 
the literature reviews have maintained that there is no 
conclusive evidence to support the notion that both short- 
and long-term Cr use may adversely affect kidney and 
liver function in healthy individuals (Farquhar and Zam-
braski, 2002; Groeneveld et al., 2005; Kreider et al., 2003; 
Mayhew et al., 2002; Mihic et al., 2000; Pline and Smith, 
2005; Poortmans and Francaux, 1999; 2000; Poortmans et 
al., 1997; Robinson et al., 2000; Terjung et al., 2000; 
Waldron et al., 2002; Yoshizumi and Tsourounis, 2004). 
With respect to the potential side effects of Cr supplemen-
tation, kidney damage was based on anecdotal human 
case reports only when associated with use of high dose 
Cr or renal disease (Ghosh and Sil, 2007; Koshy et al., 
1999; Pritchard and Kalra, 1998; Thorsteinsdottir, et al. 
2006). 
Nonetheless, since rats were used in this study and 
the basal metabolism rate, conversion and assimilation of 
organic combinations are much more intense in these 
animals, an extrapolation of Cr doses was necessary to 
facilitate demonstration its potential for side effects on 
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organs that are involved in its metabolism. The choice of 
the adopted regimen for the Cr supplementation dosage in 
this study was considered supraphysiological when com-
pared with other animal studies (Brannon et al., 1997; 
Gagnon et al., 2002; McGuire et al., 2002; Young and 
Young, 2007). 
 
 
 
 
Figure 4. Representative photomicrographs of kidney from 
Normal diet Sedentary (SED), Creatine diet Sedentary 
(CRESED), Normal diet Exercised (EXE), Creatine diet 
Exercised (CREEXE) groups after 4 weeks of supplementa-
tion.  Magnification 400x. Scale bar = 25µm. The SED group (panel A) 
had renal corpuscles with a thin contour and well defined Bowman 
capsules (continuous arrows). Glomerular capilar (dotted arrow) were 
not congested and had intra-capsular spaces preserved. Renal tubules 
showed preserved cellular morphology (cuboid epithelium) and distinct 
lumen, plus proximal tubule convoluted (stars). In CRESED group 
(panel B), possible renal damage morphology was verified: renal cor-
puscles with outline of difficult delimitation and irregularity of the 
Bowman´s Capsule (continuous arrow), dilation of capillary glomeruli 
(dotted arrow) and intra-capsular space not preserved. Renal Tubules 
exhibited cellular morphologic regularity (cuboid epithelium), but 
indefinite space tubular (arrowsheads). Panels A, C and D, show kidney 
(cortex part) with preserved renal morphology: Renal corpuscles with 
very defined outline and regularity of the Bowman´s Capsule (continu-
ous arrow), no dilation of glomeruli capillary (dotted arrow) and intra-
capsular space preserved. Renal Tubules exhibited cellular morphologic 
regularity (cuboid epithelium), and definite tubular space (arrowheads). 
 
In the present study we demonstrated that in non 
trained rats Cr supplementation (CRE group) increased 
the levels of urea and creatinine, both markers of renal 
toxicity, at four and eight weeks (Figure 2A-B and 3A-B, 
respectively). Histological analysis of kidneys of CRE 
group showed: cortical area with the presence of indefi-
nite renal corpuscles and difficult delimitation of the 
Bowman´s capsule, congestion of glomeruli capillary, and 
intra-capsular and tubular spaces not preserved, which 
indicated tissue damage (Figure 4B). In addition, the same 
experimental group (CRE) also demonstrated after eight 
weeks of Cr supplementation increase of AST, ALT, 
GGT and AP plasma levels of (Figures 3C-F, respec-
tively), and possible hepatic damage morphology was 
verified: congested central vein with some polymor-
phonuclear in the peripheral position, walls of the sinu-
soids showed numerous Kupffer cells and with swelling 
lumen by the blood cells (Figure 5B). These findings that 
supraphysiological doses of creatine may negatively im-
pact hepatic and renal function are evidence that the low-
est recommended doses of creatine should be followed for 
the most efficacious and safe outcomes. It is important to 
explicit that more is not always better (Schilling et al., 
2001).  
 
 
 
 
Figure 5. Representative photomicrographs of liver from 
Normal diet Sedentary (SED), Creatine diet Sedentary 
(CRESED), Normal diet Exercised (EXE), Creatine diet 
Exercised (CREEXE) groups after 8 weeks of supplementa-
tion. Magnification 400x. Scale bar = 25µm. The SED group (panel A) 
had a central vein which was uncongested (star), normal hepatocytes 
(continuous arrows), and slight capillary sinusoids (dotted arrows). The 
hepatocytes show standard morphology with a big and centralized 
nucleus. In CRE group (panel B) possible hepatic damage morphology 
was verified: congested central vein (star) and with some polymor-
phonuclear in the peripheral position (circular delimitations), walls of 
the sinusoids showed numerous Kupffer cells (arrowheads) and with 
swelling lumen by the blood cells (star). The EXE group (panel C) 
showed hepatocytes (continuous arrows) distributed throughout inter-
connected plates from the central vein (star) and separated by slight 
capillary sinusoids (dotted arrows). The EXECRE group (panel D) had 
preserved hepatic morphology: central vein with no congested (star), 
hepatocytes (dotted arrows) correctly arranged in trabecules running 
radiantly from the central vein and separated by thin sinusoids (continu-
ous arrows). They were regular and contained a large spheroid nucleus. 
 
As part of possible toxic mechanisms of Cr 
supplementation, we could consider the Cr accumulation 
into the tissue, which has low metabolic capacity to 
convert Cr into creatinine and is enzymatically capable of 
accomplishing the metilation processes, contributing to 
the formation of citotoxic substances, such as 
formaldeyde and methylamine (Clayton et al., 2004; Yu 
and Deng, 2000). Additionally, long-term Cr 
supplementation stimulates down- regulation of Cr 
receptors (CT-1) in skeletal muscles, blocking any 
additional storage of this nutrient (Guerrero-Ontiveros 
and Wallimann, 1998). Greenhaff (1997) demonstrated 
that muscular Cr capitation is independently saturated 
after the loading phase, with or without exercise. 
Therefore, long-term Cr supplementation results in 
increased Cr concentrations in other organs that present 
very low basal Cr storage, such as kidneys and liver 
(Ipsiroglu et al., 2001), which favor the conversion to 
citotoxic compounds. In the present study, the sedentary 
animals may have reached their maximum capacity of 
intramuscular Cr storage, and excessive Cr may have 
been capitates by renal and hepatic tissue causing some 
lesion. These findings could justify the elevation of 
plasma  levels  of  tissue  enzymes  enzymatic observed in  
Creatine supplementation damages liver and kidney  
 
 
 
678 
the CRE group.  
It is important also to note that some enzymatic re-
sults could also represent a false-positive renal and he-
patic toxicity. Since Cr is a substrate for creatinine syn-
thesis, the elevations of creatinine levels observed in the 
CRE group at four and eight weeks of supplementation 
could represent simply the result of high-dose supplemen-
tation (Poortmans  et al., 1997, Yoshizumi and Tsour-
ounis, 2004). Contrary, a recent study does not indicate 
creatinine elevation after Cr supplementation (Poortmans 
et al., 2005). Focusing on the endogenous synthesis of Cr, 
the arginine, one of the precursory synthesized amino 
acids, also served as precursor for urea production. The 
Cr supplementation could supply an additional source of 
arginine to increase urea production (Deshmukh et al., 
1991; Ööpik et al., 1996). In addition, in exercised (EXE) 
and exercised plus Cr supplemented group (EXECRE) 
after 1 week, we observed an increased level of AST 
when compared to the Control groups (Figure 1C). These 
results could be attributed to muscular alterations and not 
for Cr supplementation, because other studies demon-
strate that physical exercise in initial periods of adaptation 
can generate muscular damage, characterized by plas-
matic AST elevation (Peake et al., 2005; Van Der Meulen 
et al., 1991). However, our results were not attributed to 
false-positive because use high-dose Cr supplementation 
affected only the CRE group and it were reinforced by 
histological findings. 
Although many studies on creatine using animal 
models have been published, few have specifically fo-
cused on safety and toxicity and there is evidence that Cr 
supplementation at doses analogous than those used in 
humans do not cause adverse effects in most animals 
under normal conditions (Shao and Hathcock, 2006). For 
example, Taes et al. (2003) have indicated no deleterious 
effect in sedentary and in pre-existing renal failure rats. In 
contrast, Edmunds et al. (2001) and Ferreira et al. (2005) 
demonstrated creatine-induced deleterious effects in rats 
with cystic kidney disease and in sedentary animals, re-
spectively. Tarnopolsky et al. (2003) showed significant 
hepatic inflammatory lesions in mice associated with Cr 
supplementation, and no negative effect of Cr on liver 
histology in the Sprague-Dawley rats after intermediate-
term or long-term supplementation. These conflicting data 
may be related to differences in the protocol, species, and 
tissues analyzed. 
In recent years, it has been investigated the reduc-
tion of possible side effects of Cr supplementation when 
associated to physical exercise (Ferreira et al., 2005; 
Vieira et al., 2008b). Interestingly, although we have used 
a supraphysiological doses, the renal and hepatic damage 
were not observed in animals that were Cr supplemented 
and submitted to swimming training (EXECRE). Re-
searchers suggest that Cr and PCr diffuse between 
mitochondrial production sites and muscle utilisation sites 
(Greenhaff, 1997; Walker, 1979). This diffusion process 
was named as the ‘phosphorylcreatine shuttle’ and in-
volves 3 areas: (i) a peripheral terminus located at the 
utilisation site, which in the case of muscle is the myosin 
heads; (ii) an energy generating terminus which is located 
at the mitochondria; and (iii) a transversible space be-
tween the areas of production and utilisation (Volek and 
Kraemer, 1996). Although we have no measured the Cr 
intramuscular it is possible speculate that exercise training 
could protect against kidney and liver alterations, by in-
creasing Cr consumption by skeletal muscles during 
swimming, resulting in a decreased Cr accumulation in 
the kidneys and liver. These results corroborate previous 
studies which demonstrated that “recommended” doses of 
Cr supplementation in healthy and active animals did not 
change the organs function (Ferreira et al., 2005; Vieira et 
al., 2008b). 
Overall, the results of the current study showed 
that instituting swimming at 80% of the maximal load, 
five times a week with training daily sessions of 60 min-
utes may result in a significantly lower side effect of high-
dose Cr supplemented for the animal model examined. 
However, it should be noted that the findings of the cur-
rent study are not applicable to a Cr supplementation at 
“recommended” doses. 
 
Conclusion 
 
The results of the current study add to the growing body 
of knowledge regarding acute and chronic effects of Cr 
supplementation on renal and hepatic function using an 
animal model. Therefore, we conclude that physical activ-
ity can avoid the development of kidney and liver side 
effects of long-term supraphysiological doses of Cr sup-
plementation. However, further studies are necessary to 
clarify the metabolism of long-term Cr supplementation, 
as well as the possible side effects in organs such as kid-
neys and liver, and their health consequences, especially 
in sedentary populations that could to necessity to use this 
compound. 
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Key points 
 
• Creatine supplementation is an established er-
gogenic aid in sports and is now claimed to have 
therapeutical applications in a variety of diseases. 
• Although acknowledged, this nutritional supplement 
is rarely monitored precisely about their possible 
side effects. 
• Previous studies indicated that short-term creatine 
supplementation associate with the physical exercise 
may be safe, but the effect of long-term creatine 
supplementation is still unknown. 
• There is a need for further research to elucidate the 
controversial points refers to renal and hepatic func-
tion after creatine supplementation. 
• The results of the current study indicate that supra-
physiological long-term creatine supplementation 
(up to 4-8 weeks) may adversely affect kidney and 
liver structure and function of sedentary but not of 
exercised rats. 
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